Get started
Author

Lavanya Diwakar

Observed names: Diwakar, L, Diwakar, Lavanya, L Diwakar, L. Diwakar, Lavanya  Diwakar
Observed institutions: University Hospitals Birmingham NHS Foundation Trust, Royal Children's Hospital, Inserm, Institut Pasteur, University of Cape Town, The University of Melbourne, Czech Academy of Sciences, Queen Elizabeth Hospital Birmingham, Ealing Hospital, University Hospitals of North Midlands NHS Trust, Royal Stoke University Hospital, St Helier Hospital, Heartlands Hospital, Médecins Sans Frontières, Czech Academy of Sciences, Institute of Microbiology, Murdoch Children's Research Institute, Ealing Hospital NHS Trust, Institute of Infectious Disease and Molecular Medicine, University of Birmingham
ORCID: 0000-0003-4369-6637
Observed ORCID: 0000-0003-4369-6637
OpenAlex ID: A5016042953
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 2,153
PDF
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 562
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 508
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 393
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 354
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 302
Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines
2011 · M. T. Krishna, P. W. Ewan, et al. · Clinical & Experimental Allergy · 220
Effect of HIV-1 Infection on T-Cell–based and Skin Test Detection of Tuberculosis Infection
2006 · Molebogeng Xheeda Rangaka, Katalin A. Wilkinson, et al. · American Journal of Respiratory and Critical Care Medicine · 212
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 139
Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase
2014 · M T Krishna, M York, et al. · Clinical & Experimental Immunology · 135
A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding
2015 · T Justin Clark, Lee J Middleton, et al. · Health Technology Assessment · 86
Outpatient versus inpatient uterine polyp treatment for abnormal uterine bleeding: randomised controlled non-inferiority study
2015 · N. A. M. Cooper, T. J. Clark, et al. · BMJ · 83
PDF
Clinical, Immunological, and Epidemiological Importance of Antituberculosis T Cell Responses in HIV-Infected Africans
2007 · M. X. Rangaka, L. Diwakar, et al. · Clinical Infectious Diseases · 83
The Percutaneous shunting in Lower Urinary Tract Obstruction (PLUTO) study and randomised controlled trial: evaluation of the effectiveness, cost-effectiveness and acceptability of percutaneous vesicoamniotic shunting for lower urinary tract obstruction
2013 · RK Morris, GL Malin, et al. · Health Technology Assessment · 63
PDF
Systematic review of pathways for the delivery of allergy services
2017 · Lavanya Diwakar, Carole Cummins, et al. · BMJ Open · 61
PDF
Does rituximab aggravate pre-existing hypogammaglobulinaemia?: Table 1
2010 · Lavanya Diwakar, Sheryl Gorrie, et al. · Journal of Clinical Pathology · 56
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 41
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK
2022 · Adrian M Shields, Ariharan Anantharachagan, et al. · Clinical & Experimental Immunology · 37
PDF
Atraumatic splenic rupture due to covid-19 infection
2020 · Irfan Shaukat, Raisa Khan, et al. · Clinical Infection in Practice · 37
PDF
National Survey of United Kingdom Paediatric Allergy Services
2022 · Rosy Wells, Cathy McKay, et al. · Clinical & Experimental Allergy · 36
A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis
2023 · Joan Mendivil, Maral DerSarkissian, et al. · Allergy Asthma and Clinical Immunology · 35
PDF
Results of the randomised controlled trial
2015 · T. Justin Clark, Lee Middleton, et al. · 35
An economic evaluation of outpatient versus inpatient polyp treatment for abnormal uterine bleeding
2015 · L Diwakar, TE Roberts, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 33
Prescription rates of adrenaline auto-injectors for children in UK general practice: a retrospective cohort study
2017 · Lavanya Diwakar, Carole Cummins, et al. · British Journal of General Practice · 31
PDF
Works count: 123
Citation count: 6,010
H-index: 26
I10-index: 34
Year
Topic
Type